KPMG has hit back at a shareholder class action over allegedly misleading statements made ahead of CuDecoâs collapse in 2020, placing blame on the defunct mining company, its directors and group members themselves.Â
Construction firm CIMIC has won its bid to view identifying information about institutional investors in a shareholder class action, despite the applicant’s claims it could deter group members from signing on to the case.Â
Gold Coast âfinfluencerâ Tyson Scholz has been permanently barred from conducting a financial services business without a license, after a court found he provided illegal financial services by giving tips on his Instagram account and to customers who paid for access to his seminars and âBlack Wolf Pitâ chat room.
A judge has approved a walk-away settlement with two former directors of RCR Tomlinson in a shareholder class action against the failed engineering company.
Infrastructure services company Downer EDI has been hit with a class action after revealing “accounting irregularities” that sent its share price tumbling.
A shareholder class action against Medibank has claimed it did not disclose âserious deficienciesâ in its cybersecurity measures, including failing to implement security measures such as multi factor authentication, causing investors to buy shares at inflated prices.Â
Westpac has hit back at a bid by ASIC to add an allegation to the regulator’s insider trading case that hinges on the bank providing financial services when it traded on the morning of a $16 billion deal to privatise electricity provider Ausgrid.
Australia’s largest private health insurer Medibank has been hit with a shareholder class action in the wake of a massive cyberattack that left the data of 10 million customers exposed.
The corporate watchdog has commenced a probe into ASXâs handling of the CHESS replacement program, including in relation to possible continuous disclosure breaches and misleading or deceptive conduct.
Beauty giant McPhersonâs has denied ASIC’s claims that it misled the market and breached its disclosure obligations in 2020, arguing that a document showing sales of its Dr LeWinnâs line were down by $21 million was a draft that couldnât have been used to revise a financial forecast.